FIELD: medicine; pharmacology.
SUBSTANCE: substance of invention includes human polypeptide or its functional fragment containing sequence SEQ ID NO:2 or polynucleotide-encoded, containing sequence corresponding to SEQ ID NO:1. Furthermore, the invention includes methods of abatement and compound screening which can be used for modulation or pain prevention.
EFFECT: extended application.
30 cl, 1 tbl, 14 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| S1P APPLICATION | 2004 |
|
RU2362565C2 |
| PURIFIED IMMUNOGENIC PROTEIN, ITS FRAGMENTS AND DERIVATIVES | 1999 |
|
RU2304585C2 |
| METHODS FOR MAKING POLYCLONAL ANTIBODIES, ANTISERUM CONTAINING POLYCLONAL ANTIBODIES, AND METHODS FOR IMMUNISATION | 1999 |
|
RU2358982C2 |
| VERSIONS OF ERYTHROPOETINE | 2006 |
|
RU2430162C2 |
| POLYNUCLEOTIDE MODULATING CANCER CELL PROLIFERATION (VARIANTS), POLYPEPTIDE, MONOCLONAL ANTIBODY, EXPRESSION VECTOR, HOST CELL, PHARMACEUTICAL AGENT FOR TREATMENT OF PROLIFERATIVE DISEASE, PHARMACEUTICAL COMPOSITION, POLYPEPTIDE USES IN PHARMACEUTICAL AGENT PRODUCTION | 2002 |
|
RU2307666C2 |
| COMPOSITIONS AND METHODS OF MAMMARY GLAND CANCER THERAPY AND DIAGNOSTICS | 2001 |
|
RU2344831C2 |
| LIGAND GITR AND MOLECULES AND ANTIBODIES BOUND WITH LIGAND GITR, AND VERSIONS OF THEIR APPLICATION | 2004 |
|
RU2369636C2 |
| USE OF CATHEPSIN H | 2010 |
|
RU2574005C2 |
| COMPOSITIONS AND METHODS FOR TREATING AND PREDICTING PULMONARY CANCER | 2001 |
|
RU2311920C2 |
| POLYPEPTIDE WITH PHOSPHODIESTERASE ENZYMATIC ACTIVITY | 1998 |
|
RU2272841C2 |
